Author:
Brennan Donal J,Brändstedt Jenny,Rexhepaj Elton,Foley Michael,Pontén Fredrik,Uhlén Mathias,Gallagher William M,O'Connor Darran P,O'Herlihy Colm,Jirstrom Karin
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference38 articles.
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008, 58 (2): 71-96. 10.3322/CA.2007.0010.
2. Mo H, Elson CE: Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med. 2004, 229 (7): 567-585.
3. Liao JK: Isoprenoids as mediators of the biological effects of statins. J Clin Invest. 2002, 110 (3): 285-288.
4. Wejde J, Blegen H, Larsson O: Requirement for mevalonate in the control of proliferation of human breast cancer cells. Anticancer Res. 1992, 12 (2): 317-324.
5. Sivaprasad U, Abbas T, Dutta A: Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells. Mol Cancer Ther. 2006, 5 (9): 2310-2316. 10.1158/1535-7163.MCT-06-0175.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献